newsfilter
← Latest News
GlobeNewswire·

180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren's Disease

PALO ALTO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced the publication of a review entitled ‘Treatments for early stage